Methods and reagents to detect and characterize norwalk and related viruses |
| OF THE INVENTION It is readily apparent to one skilled in the art that various substitutions and ... |
|
Human medical treatment by aerosol inhalation of immunoglobulin A |
| OF THE PREFERRED EMBODIMENTS The following description of the preferred embodiment(s) is merely ... |
|
Cell culture process and medium for the growth of adherent animal cells |
| We have now found that it is possible to eliminate cell aggregation in the culture of CHO-derived ... |
|
Reactor heater |
| Having thus described our invention and certain embodiments thereof, we claim: 1. In combination, a ... |
|
Electrical leads for a fluid heaters |
| The present invention sets forth a method and a structure for connecting electrical power to the ... |
|
Electric radiant heater and method for its manufacture |
| OF A PREFERRED EMBODIMENT FIG. 1 shows a radiant heater provided for fitting below a cooking ... |
|
Substrate heating mechanism |
| An object of the present invention is to provide a substrate-heating mechanism in a film formation ... |
|
Method and apparatus for producing an electrically conductive wall from a fabric and a sheet material |
| It is therefore an object of the present invention to provide a method of the initially named type, ... |
|
Nozzle for coating optical fibers |
| I claim: 1. A nozzle for applying a protective resin coating to optical fibers, comprising a body ... |
|
Coating head assembly for elongated strands |
| An object of the present invention is to provide a split coating head assembly for elongated ... |
|
|
Antiviral peptides
| Details |
Inventors: Schlesinger, Milton J.; Adams, Steven P.;
Assignee: Washington University (St. Louis, MO)
Primary Examiner: Lee; Lester L.
Assistant Examiner:
Attorney, Agent or Firm: Meyer; Scott J., Williams, Jr.; James W.
Novel antiviral peptides are disclosed which have a sequence of about 4 to 10 amino acids and which are substantially identical to a small portion of the cytoplasmic domain of a glycoprotein in a virus that contains a lipid-bilayer in its structure. |
|
DETAILED DESCRIPTION OF THE INVENTION While the specification concludes with claims particularly pointing out and specifically claiming the subject matter regarded as forming the present invention, it is believed that the invention will be better understood from the following detailed description of preferred embodiments taken in conjunction with the accompanying drawing in which: FIG. 1 is a schematic which shows the initiation of Sindbis virus assembly, including the host cell plasma membrane, the virus nucleocapsid, the cytoplasmic domain of glycoprotein E2, and the application of an antiviral peptide (blocking peptide) in one embodiment of the invention. The novel antiviral peptides of this invention can be prepared by known solution and solid phase peptide synthesis methods. In conventional solution phase peptide synthesis, the peptide chain can be prepared by a series of coupling reactions in which the constituent amino acids are added to the growing peptide chain in the desired sequence. The use of various N-protecting groups, e. g. , the carbobenzyloxy group or the t-butyloxycarbonyl group (BOC), various coupling reagents, e. g. , dicyclohexylcarbodiimide or carbonyldimidazole, various active esters, e. g. , esters of N-hydroxyphthalimide or N-hydroxy-succinimide, and the various cleavage reagents, e. g. , trifluoroacetic acid (TFA), HCL in dioxane, boron tris-(trifluoracetate) and cyanogen bromide, and reaction in solution with isolation and purification of intermediates is well-known classical peptide methodology. The preferred peptide synthesis method follows conventional Merrifield solid-phase procedures. See Merrifield, J. Amer. Chem. Soc. 85, 2149-54 (1963) and Science 150, 178-85 (1965). This procedure, though using many of the same chemical reactions and blocking groups of classical peptide synthesis, provides a growing peptide chain anchored by its carboxy terminus to a solid support, usually cross-linked polystyrene, styrenedivinylbenzene copolymer or, preferably, p-methylbenzhydrylamine polymer for synthesizing peptide amides
|
| Related patents |
|
|
Immunoglobulins devoid of light chains
We claim: 1. An immunoglobulin comprising two heavy polypeptide chains, each heavy chain consisting of a complete antigen binding site, said immunoglobulin containing a ...
|
|
|
Buffered serum substitute for blood oxygen analyzer
What is claimed is: 1. A buffered serum substitute for receiving a blood sample, said serum substitute comprising a 0.9% saline solution containing 5 millimolar of ...
|
|
|
Analytical method for determining volatiles, solids and solvent extractables
What is claimed is: 1. A method for determining amounts of volatiles, solids, and solvent extractable solid in a sample containing the same comprising placing the sample ...
|
|
|
Methods for determining the invasiveness of a bladder tumor
Briefly stated, the present invention provides, in one aspect, methods for determining the invasiveness of a bladder tumor. In one embodiment, the method comprises the ...
|
|
|
Compounds for inhibition of protein methylation
In general, the invention features certain novel compounds which inhibit methylation of proteins having a carboxyl-terminal --CAAX motif (C=cysteine, A=aliphatic amino ...
|
|
|
Inhibitors of farnesyl protein transferase
OF THE INVENTION Definition of Terms Listed below are definitions of various terms used to describe this invention. These definitions apply to the terms as they are ...
|
|
|
Cerulenin compounds for fatty acid synthesis inhibition
OF THE INVENTION I. FAS The protein FAS (also referred to herein as OA-519) is highly correlated with the most virulent carcinomas. FAS exhibits fatty acid synthase ...
|
|
|
Inhibitors of prenyl-protein transferases
OF THE INVENTION The compounds of this invention inhibit the prenylation of proteins by the enzymes geranylgeranyl protein transferase and farnesyl-protein transferase. ...
|
|
|
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
OF THE INVENTION As used herein, the following terms are used as defined below unless otherwise indicated: M.sup.+ -represents the molecular ion of the molecule in the ...
|
|
|
Genetic alterations associated with cancer
The present invention provides compositions and methods for detecting genetic alterations correlated with cancer. The invention can be used to detect alterations in a 2 M...
|
|
|